Fundraising Fox

Windgap Medical

Watertown, US · Founded 2011 · Delaware corporation · 4 known investors

windgapmedical.com ↗
Biotechin /windgap-medical

Founders & leadership

BB
Brent BuchineDirector
MM
Max MeehanExecutive Officer
AM
Aaron MannExecutive Officer, Director
JD
Jason DurkinExecutive Officer
JC
John CadiganExecutive Officer
AW
Anthony WatsonExecutive Officer
JM
J. Melville EngleDirector
TK
Tim KrochukDirector
RG
Richard GabrielDirector
CS
Christopher StepanianExecutive Officer, Director
RR
Richard RussellDirector
TK
Timothy KrochukDirector

Investors · 4

Bantam GroupWestwood
Boston Harbor AngelsBoston · $250K – $1.5M
Colle Capital PartnersNew York · $500K – $2M
Launchpad Venture GroupBoston · $8M – $10M

Reported raises · per SEC filings

Form D private placements
▶$12.7MraisedJan 2026 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Max MeehanExecutive Officer
  • Richard RussellDirector
  • Brent BuchineDirector
  • Timothy KrochukDirector
  • Aaron MannExecutive Officer, Director
  • Jason DurkinExecutive Officer
  • John CadiganExecutive Officer
  • Anthony WatsonExecutive Officer
  • John Reading WilsonDirector
Offering amount
$17.3M
Amount sold
$12.7M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$39.2MraisedJan 2022 · 46 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael HuangDirector
  • Richard RussellDirector
  • John Reading WilsonDirector
  • Christopher StepanianExecutive Officer, Director
  • Brent BuchineExecutive Officer, Director
  • John ConleyDirector
Offering amount
$42.2M
Amount sold
$39.2M
First sale
Aug 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$360.5KraisedMar 2020 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Brent BuchineExecutive Officer, Director
  • Christopher StepanianExecutive Officer, Director
  • J. Melville EngleDirector
  • John ConleyDirector
  • Tim KrochukDirector
  • John Reading WilsonDirector
  • Richard GabrielDirector
Offering amount
$2M
Amount sold
$360.5K
First sale
Feb 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.2MraisedJan 2019 · 106 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John Reading WilsonDirector
  • Richard GabrielDirector
  • John ConleyDirector
  • J. Melville EngleDirector
  • Tim KrochukDirector
  • Brent BuchineExecutive Officer, Director
  • Christopher StepanianExecutive Officer, Director
Offering amount
$39M
Amount sold
$12.2M
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedJul 2018 · 75 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard GabrielDirector
  • J. Melville EngleDirector
  • Tim KrochukDirector
  • Christopher StepanianExecutive Officer, Director
  • Brent BuchineExecutive Officer, Director
  • John ConleyDirector
Offering amount
$4M
Amount sold
$3.8M
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedApr 2016 · 46 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher StepanianExecutive Officer, Director
  • Richard GabrielDirector
  • Tim KrochukDirector
  • J. Melville EngleDirector
  • John ConleyDirector
  • Brent BuchineExecutive Officer, Director
Offering amount
$4M
Amount sold
$2.9M
First sale
Mar 2016
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedAug 2015 · 92 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John ConleyDirector
  • Richard GabrielDirector
  • Brent BuchineExecutive Officer, Director
  • Christopher StepanianExecutive Officer, Director
  • Tim KrochukExecutive Officer
  • J. Melville EngleDirector
Offering amount
$4.5M
Amount sold
$4.2M
Minimum investment
$4.2K
Proceeds to insiders
$465K
First sale
May 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedMay 2015 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • J. Melville EngleDirector
  • Tim KrochukDirector
  • John ConleyDirector
  • Richard GabrielDirector
  • Brent BuchineExecutive Officer, Director
  • Christopher StepanianExecutive Officer, Director
Offering amount
$250K
Amount sold
$250K
Minimum investment
$250K
First sale
May 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.